✦ LIBER ✦

India forced to change its drug patent legislation

✍ Scribed by Sanjay Kumar

Book ID: 117294369
Publisher: The Lancet
Year: 1999
Tongue: English
Weight: 52 KB
Volume: 353
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)74913-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Committee to regulate patented drug pric

Committee to regulate patented drug prices in India

✍ Kulyako, Y. M.; Perevalov, S. A.; Trofimov, T. I.; Malikov, D. A.; Vinokurov, S. 📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 199 KB

Legislation change fails to reduce drug

Legislation change fails to reduce drug spend in Iceland

✍ Greener, Mark 📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 135 KB

The stock market response to changing dr

The stock market response to changing drug patent legislation: The case of compulsory licensing in Canada

✍ Daniel M. Shapiro; Lorne N. Switzer 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 974 KB

“To patent or not to patent? the case of

“To patent or not to patent? the case of Novartis’ cancer drug Glivec in India”

✍ Gabble, Ravinder; Kohler, Jillian 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 211 KB

From Spontaneous Adverse Drug Reporting

From Spontaneous Adverse Drug Reporting to Legislation Change of Ketorolac in Taiwan

✍ W. Chen, C. Gau, Y. Hsieh 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 48 KB

Canada to change patent law to allow exp

Canada to change patent law to allow export of cheap drugs

✍ Wayne Kondro 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 35 KB